Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

 

Cleveland Clinic Rheumatology
A

Are There Factors That Can Guide Treatment Decisions in Newly Diagnosed and Relapsing Takayasu Arteritis?

By Cleveland Clinic Rheumatology FEATURING Alexandra Villa-Forte
By Cleveland Clinic Rheumatology FEATURING Alexandra Villa-Forte
48 views
April 18, 2023
0 Comments
Login to view comments. Click here to Login
Biologic Therapies Summit IX, 2021
29:06
Cleveland Clinic Rheumatology

Vaccines for IMIDS: State of the Art

Feat. C. Calabrese
32:34
Cleveland Clinic Rheumatology

Advances in Pulmonary Aspects of Progressive Systemic Sclerosis

Feat. K. Highland
27:37
Cleveland Clinic Rheumatology

Targeted Theories in irAES

Feat. K. Esfahani
21:36
Cleveland Clinic Rheumatology

Safety of Biologics and JAK Inhibitors (Mycobacterial Infections)

Feat. K. Winthrop
20:09
Cleveland Clinic Rheumatology

ANCA and Endocarditis

Feat. A. Brown
40:36
Cleveland Clinic Rheumatology

Taking a Closer Look at RA Treatments With a Focus on JAKi: New drug…

Feat. S. Cohen
43:51
Cleveland Clinic Rheumatology

What do we Really Know About Non-Radiographic Spondyloarthropathy?

Feat. M. Magrey
09:25
Cleveland Clinic Rheumatology

What's New in PsA: Case Presentation

Feat. J. Yedimenko
07:07
Cleveland Clinic Rheumatology

What’s New in RA: Case Presentation

Feat. E. Littlejohn
09:59
Cleveland Clinic Rheumatology

What’s New in SpA: Case Presentation

Feat. S. Keller
33:23
Cleveland Clinic Rheumatology

Evolving Treatment Strategies in PsA: How do we Choose?

Feat. A. Kavanaugh
26:31
Cleveland Clinic Rheumatology

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

Feat. R. Q. Cron
29:14
Cleveland Clinic Rheumatology

Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet

Feat. D. Fajgenbaum
32:56
Cleveland Clinic Rheumatology

COVID-19 and Autoimmunity

Feat. P. Utz
35:13
Cleveland Clinic Rheumatology

COVID-19: What Have we Learned in One Year?

Feat. L. Calabrese
21:21
Cleveland Clinic Rheumatology

What Have Registries Taught Us?

Feat. J. Yazdany
24:22
Cleveland Clinic Rheumatology

Does Plasma Exchange Have a Role in Patients With ANCA-Associated Va…

Feat. M. Walsh
20:03
Cleveland Clinic Rheumatology

What Dose and Duration of Glucocorticoids Should be Used in ANCA-Ass…

Feat. P. Merkel
16:17
Cleveland Clinic Rheumatology

A Vasculitis Case Presentation

Feat. C. Gota
15:04
Cleveland Clinic Rheumatology

Vasculitis Treatment Case Presentation

Feat. A. Brown
20:17
Cleveland Clinic Rheumatology

When Should Biologic Agents be Considered in Eosinophilic Granulomat…

Feat. M. Wechsler
19:31
Cleveland Clinic Rheumatology

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Feat. A. Villa-Forte
25:36
Cleveland Clinic Rheumatology

When Should Biologic Agents be Introduced in Giant Cell Arteritis an…

Feat. K. Warrington
17:58
Cleveland Clinic Rheumatology

What Are the Options for Treating CNS Vasculitis?

Feat. R. Hajj-Ali
21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
21:33
Cleveland Clinic Rheumatology

Is There Still a Role for Conventional Immunosuppressive Agents in A…

Feat. C. Langford
23:51
Cleveland Clinic Rheumatology

Maintenance Rituximab in ANCA-Associated Vasculitis: Dose, Frequency…

Feat. R. Smith
21:40
Cleveland Clinic Rheumatology

How Does the Treatment of Behçet’s Disease Differ Based on Disease M…

Feat. G. Hatemi